Introducing the BTKi-SLE Study:
a Systemic Lupus Erythematosus clinical research study
Living day in, day out with systemic lupus erythematosus (SLE) can be challenging. It takes courage and persistence. If you have SLE, could a clinical research study be an option for you?
The BTKi-SLE Study is a global clinical research study evaluating an investigational medication for people with SLE.
SLE is an autoimmune disease that can affect many parts of the body, including the skin, muscles and joints, and even organs located inside your body. This global study will be investigating the safety and effectiveness of an investigational medication in people with SLE. This global study will assess 3 doses of the investigational medication compared to placebo (a pill with no medicine in it).
Thank you for considering this clinical research study.
Learn more about this study
This website is supported by EMD Serono.